中国同辐启运首批碳-14同位素产品
5月19日，中国同辐（01763）发布公告，2025年5月16日成功启运首批碳-14同位素产品。
其标志着我国商用堆产碳-14同位素实现了从自主研发、自主生产到市场化供应的全产业链贯通。此次上市的碳-14同位素产品由中核秦同自主设计、建设的国内首条百居里级碳-14酸钡工业化生产线生产，设计年产能达到200居里/年，采用高效干法工艺提取，具备生产效率高、设备自动化水平高等优势。
目前，中核秦同已完成10居里的纯化加工，其比活度≥290mCi/g，放射性核纯度≥99.9%，达到了国际先进水平。后续将根据市场需求量进行加工生产和销售。
此外，中核秦同还投资建设了5条同位素生产线，涵盖碳-14、锶-89、碘-131、钴-60放射源和特定核素，未来将继续响应国家“健康中国”战略，为行业高质量发展贡献力量。
（文章来源：财中社）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10